Open Access

Recurrent acute myocardial infarction with coronary artery aneurysm in a patient with Behçet's disease: a case report

  • Sepideh Sokhanvar1Email author,
  • Marjaneh Karimi2 and
  • Abdolreza Esmaeil-zadeh3
Journal of Medical Case Reports20093:8869

DOI: 10.4076/1752-1947-3-8869

Received: 21 October 2008

Accepted: 13 February 2009

Published: 20 August 2009



Behçet's disease is an inflammatory disorder of unknown origin, with mucocutaneous, ocular, articular, vascular, gastrointestinal and central nervous system manifestations. Although cardiac involvement is not an uncommon manifestation of Behçet's disease, coronary aneurysm has rarely been reported.

Case presentation

A 36-year-old Iranian man was admitted to our emergency department for retrosternal pain of two and a half hours duration. His detailed medical history revealed that he had no risk factors for coronary artery disease, however, Behçet's disease had been diagnosed about 10 years earlier. His electrocardiogram showed inferior myocardial infarction. He underwent coronary angiography that showed multiple giant aneurysms in his coronary arteries. Two months later, he experienced another episode of unstable angina. This was followed by two episodes of anterior myocardial infarction 2 and 5 months afterwards.


This case highlights the importance of careful diagnostic work-up in the evaluation of myocardial infarction in patients. In our patient, Behçet's disease proved to be the cause of recurrent myocardial infarction.


Coronary artery disease is one of the most common causes of acute myocardial infarction. In addition to atherosclerosis, coronary vasculitis may also cause acute coronary syndrome [1]-[3]. One of the most common characteristics of Behçet's disease (BD) is vasculitis, which rarely involves the coronary arteries [4, 5]. However, data on the clinical significance of coronary artery involvement are very limited. In BD, acute myocardial infarction is a serious complication and an important clinical manifestation of coronary arteritis. Myocardial infarction due to coronary vasculitis in BD is infrequent and few cases have been documented in the literature [1]-[3]. We report the case of a patient with BD presenting with recurrent myocardial infarction due to coronary vasculitis with diffuse fusiform coronary aneurysms.

Case presentation

A 36-year-old Iranian man was admitted to our emergency department on 31 August 2006, presenting with epigastric and retrosternal pain of two and a half hours duration. His detailed medical history revealed that he had no risk factors for coronary artery disease, however, BD had been diagnosed 10 years earlier and he was on colchicine 1 mg/day. Oral aphthous ulcers were exacerbated during coronary artery events. Eye examination was normal. He had an episode of thrombophlebitis of his left leg in 2004 and had been taking warfarin but had discontinued the medication.

Medical examination revealed blood pressure of 130/70 mmHg and heart rate of 85 beats/minute and the patient was pale and perspiring. Chest auscultation revealed no abnormalities. His electrocardiogram (ECG) revealed normal sinus rhythm with ST segment elevation on II, III and aVF and reciprocal ST segment depression on V1-V6. Laboratory tests showed elevation of plasma total creatine phosphokinase (CPK) and CPK-MB activities. There were no findings consistent with coagulation and fibrinolysis disorders. He was diagnosed as having an acute inferior wall myocardial infarction, therefore nitroglycerin, heparin, aspirin and beta blocker therapies were started immediately followed by thrombolytic therapy with streptokinase within 1 hour. After 40 minutes, his chest pain was relieved and there was a significant reduction of ST segment elevation along with increased cardiac enzyme levels. A transthoracic echocardiogram showed mild apical hypokinesia and a left ventricular ejection fraction of 50%.

On the third day of hospital admission, he underwent coronary angiography. Coronary angiography revealed an 8 mm giant aneurysm of the proximal left anterior descending artery, an 8 mm aneurysm of the proximal left circumflex coronary artery (Figure 1) and a 9 mm aneurysm of the proximal right coronary artery (Figure 2). Based on clinical evidence, electrocardiogram and coronary angiography, we considered that the acute myocardial infarction in our patient was due to a coronary aneurysm. Therefore, we did not attempt any coronary intervention and decided to continue with medical therapy including azathioprine, colchicine, prednisolone, aspirin, beta blocker, nitroglycerin and enalapril. On 25 November 2006, the patient experienced another episode of chest retrosternal pain which lasted for 7 hours. His ECG revealed significant ST segment depression on V1-V6. Cardiac enzymes did not rise so he was diagnosed with unstable angina. No changes in ECG were noticed after 5 days. The patient was not adhering to drug therapy and when his coronary events occurred drug therapy was restarted. The next episode of retrosternal pain occurred on 28 February 2007 and lasted for 5 hours. His ECG showed tall T waves on precordial leads. Laboratory tests showed elevation of plasma total CK and CK-MB activities. He was diagnosed with an acute anterior wall myocardial infarction. Medical treatment was started but since he had received thrombolytic therapy 5 months earlier, streptokinase was not administered. The echocardiogram showed septal, apical and anterior wall hypokinesia with an estimated left ventricular ejection fraction of about 25-30%. He was discharged 10 days later with his previous medication plus digoxin, warfarin, frusemide, and spironolactone. On 2 August 2007, he experienced another bout of retrosternal pain that lasted for 7 hours. ECG showed ST segment elevation on precordial leads. Laboratory tests showed elevation of plasma total CK and CK-MB activities. This time, a new anterior myocardial infarction was diagnosed, medical treatment was started and azathioprine was switched for pulse cyclophosphamide 10 mg/kg, but the patient then discharged himself. At the time of writing, the patient is well with pulse cyclophosphamide every 2 months and prednisolone 7.5 mg/day, but unfortunately, he is non-compliant to drug therapy and so it was not possible to switch him to oral medication.
Figure 1

Coronary angiogram after left coronary administration of contrast material in the left anterior oblique position. The angiogram revealed an 8 mm giant aneurysm of the proximal left anterior descending artery and an 8 mm aneurysm of the proximal left circumflex coronary artery.
Figure 2

Coronary angiogram after right coronary administration of contrast material in the left anterior oblique position. The angiogram revealed a 9 mm aneurysm of the proximal right coronary artery.


Vascular involvement is a well-known characteristic of BD. Large vessel disease or acute cerebrovascular infarction in the setting of aphthosis should suggest BD [6]. It can occur even in relatively young patients with no vascular risk factors. Arterial involvement is generally expressed by thrombosis, stenosis and/or aneurysms, as shown in early studies [1]-[5]. The prevalence of coronary involvement in BD is 0.5% [7]. Aneurysms are seen less frequently than arterial occlusions [8]. The pathogenesis of the arterial lesion in BD has been well documented. An inflammatory obliterative endarteritis of the vasa vasorum, most likely brought about by immune deposition, causes destruction of media and fibrosis and thus weakens and predisposes the arterial wall to aneurysm formation that eventually ruptures [9]. In our patient, angiography was performed for evaluation of coronary anatomy. Coronary angiograms revealed multiple giant aneurysms of all coronary arteries. There was no evidence of underlying disease such as antiphospholipid syndrome, rheumatic or connective tissue disorders. In the literature, several different therapeutic approaches have been advanced for the management of myocardial infarction in patients with BD. These may include primary percutaneous transluminal coronary angioplasty (PTCA) [10, 11], repair of the aneurysm [12], or administration of fibrinolytic therapy at the early stages of acute myocardial infarction, as in our patient. Finally, the therapeutic approach remains complex, especially in recurrent myocardial infarction. It is important to perform surgical and/or interventional radiological procedures to intervene urgently for enlarging ischaemia, ruptured aneurysms or organ-threatening ischaemia. However, unless intervention is urgently required, it is prudent to postpone invasive approaches in these vascular complications until the inflammatory component of BD has been controlled with medical therapy [13].


For patients with acute myocardial infarction without any other risk factor and especially in relatively young patients, Behçet's disease should be considered as the underlying pathology.


Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.



All authors acknowledge Dr Giti Karimkhanloei who helped with manuscript revision.

Authors’ Affiliations

Cardiology Department, Medical Science University, Metabolic Research Center
Rheumatology Department, Medical Science University, Metabolic Research Center
Immunology Department, Medical Science University, Metabolic Research Center


  1. Ioakimidis D, Georganas C, Panagoulis C, Gournizakis A, Iliopoulos A, Kremastinos D, Kontomerkos T: A case of Adamantiadis-Behcet's syndrome presenting as myocardial infarction. Clin Exp Rheumatol. 1993, 11: 183-186.PubMedGoogle Scholar
  2. Kawakami Y, Nakayama Y, Nagao H, Hirota Y, Kawamura K: A case of Behcet's disease complicated with acute myocardial infarction. Kokyu To Junkan. 1991, 39: 935-938 [Japanese].PubMedGoogle Scholar
  3. Le Thi HD, Wechsler B, Kahn JC, Benhamou E, Cajfinger F, Le HP, Godeau P: Myocardial infarction in Behcet's disease. Arch Mal Coeur Vaiss. 1987, 80: 1663-1667.Google Scholar
  4. Bowles CA, Nelson AM, Hammill SC, O'Duffy JD: Cardiac involvement in Behcet's disease. Arthritis Rheum. 1985, 28: 345-348. 10.1002/art.1780280317.View ArticlePubMedGoogle Scholar
  5. Wechsler B, Du LT, Kieffer E: Cardiovascular manifestations of Behcet's disease. Ann Med Interne (Paris). 1999, 150: 542-554.Google Scholar
  6. Silman A, Gul A: Is there a place for large vessel disease in the diagnostic criteria of Behcet's disease?. J Rheumatol. 2000, 27: 2050-2051.PubMedGoogle Scholar
  7. Hutchison SJ, Belch JJ: Behcet's syndrome presenting as myocardial infarction with impaired blood fibrinolysis. Br Heart J. 1984, 52: 686-687. 10.1136/hrt.52.6.686.View ArticlePubMedPubMed CentralGoogle Scholar
  8. Kosar F, Sahin I, Gullu H, Cehreli S: Acute myocardial infarction with normal coronary arteries in a young man with the Behcet's disease. Int J Cardiol. 2005, 99: 355-357. 10.1016/j.ijcard.2003.11.039.View ArticlePubMedGoogle Scholar
  9. Matsumoto T, Uekusa T, Fukuda Y: Vasculo-Behcet's disease: a pathologic study of eight cases. Hum Pathol. 1991, 22: 45-51. 10.1016/0046-8177(91)90060-3.View ArticlePubMedGoogle Scholar
  10. Drobinski G, Wechsler B, Pavie A, Artigou JY, Marek P, Godeau P, Grosgogeat Y: Emergency percutaneous coronary dilatation for acute myocardial infarction in Behcet's disease. Eur Heart J. 1987, 8: 1133-1136.PubMedGoogle Scholar
  11. Tamura Y, Matsuoka A, Ohtaki E, Okabe M, Shibata A: Behcet's disease complicated by acute myocardial infarction treated with percutaneous transluminal coronary angioplasty. Kokyu To Junkan. 1988, 36: 341-346 [Japanese].PubMedGoogle Scholar
  12. Ozeren M, Dogan OV, Dogan S, Yucel E: True and pseudo aneurysms of coronary arteries in a patient with Behcet's disease. Eur J Cardiothorac Surg. 2004, 25: 465-467. 10.1016/j.ejcts.2003.11.040.View ArticlePubMedGoogle Scholar
  13. Calamia KT, Schirmer M, Melikoglu M: Major vessel involvement in Behcet disease. Curr Opin Rheumatol. 2005, 17: 1-8. 10.1097/01.bor.0000145520.76348.dd.View ArticlePubMedGoogle Scholar


© Sokhanvar et al.; licensee Cases Network Ltd. 2009

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.